The Core Case For Emerging Markets
If emerging markets are not already a core part of your portfolio, you may be missing out on what one analyst declares will be “the…
If emerging markets are not already a core part of your portfolio, you may be missing out on what one analyst declares will be “the…
When is a dividend stock that the market is especially bearish on a deep value buying opportunity and when is it a yield/value trap? The…
“The dividend aristocrats index tends to shine during bear markets and low return environments. However, it also pulls its weight when we are in a…
How did a self-made Brazilian billionaire lose his $35 billion empire practically overnight? The author of today’s article points to a lesson that he advises…
While the revolution from traditional retail to online retail has been underway for quite some time in developed markets, emerging markets are now seeing significant…
“New traders are often seduced by the patterns of indicators, but this work invariably ends in disappointment when results don’t follow,” notes the author of…
Gossamer Bio is a San Diego-based biotech that is readying for an initial public offering – and with a diverse pipeline including potential treatments for…
After experiencing a rough 2018, today’s article notes that “the investment case for emerging markets has vastly improved” – and highlights some specific emerging market…
“This could be gold’s year,” declares one precious metals analyst cited in today’s article on how the yellow metal, the price of which has been…
It’s probably not a surprise to learn that the stocks that were the most adored by analysts at the start of 2018 beat the overall…